CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
3.300
+0.020 (0.61%)
At close: Feb 21, 2025, 4:00 PM
3.320
+0.020 (0.61%)
After-hours: Feb 21, 2025, 6:05 PM EST
CureVac Employees
As of December 31, 2023, CureVac had 1,172 total employees, including 999 full-time and 173 part-time employees. The number of employees increased by 123 or 11.73% compared to the previous year.
Employees
1,172
Change (1Y)
123
Growth (1Y)
11.73%
Revenue / Employee
$60,210
Profits / Employee
-$254,547
Market Cap
740.24M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,172 | 123 | 11.73% |
Dec 31, 2022 | 1,049 | 165 | 18.67% |
Dec 31, 2021 | 884 | 330 | 59.57% |
Dec 31, 2020 | 554 | 100 | 22.03% |
Dec 31, 2019 | 454 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CVAC News
- 4 days ago - CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World's Top Innovators - Accesswire
- 6 weeks ago - CureVac: Latest GBM Data Bodes Well For Next Program Check Point - Seeking Alpha
- 3 months ago - CureVac N.V. (CVAC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update - Accesswire
- 3 months ago - CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024 - Accesswire
- 3 months ago - CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer - Accesswire
- 3 months ago - CureVac to Present at the 12th International mRNA Health Conference - Accesswire
- 4 months ago - CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting - Accesswire